Improve Research Reproducibility A Bio-protocol resource
- Protocols
- Articles and Issues
- For Authors
- About
- Become a Reviewer
Ana Belén Carrillo-Gálvez
Genomic Oncology Department, GENYO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalucian Regional Government, PTS Granada, Spain
Personal information
Education
Master in Research and Advances at Molecular and Cellular Immunology, University of Granada, Spain, 2012
Current position
Ph.D. student, Centre for Genomics and Oncological Research (GENYO), Spain
Publications
-
Carrillo-Galvez, A. B., Cobo, M., Cuevas-Ocaña, S., Gutiérrez-Guerrero, A., Sánchez-Gilabert, A., Bongarzone, P., Garcia-Perez, A., Muñoz, P., Benabdellah, K., Toscano, M. G., Martín, F. and Anderson, P. (2015). Mesenchymal stromal cells express GARP/LRRC32 on their surface: effects on their biology and immunomodulatory capacity. Stem Cells 33(1): 183-195.
-
Anderson, P., Carrillo-Galvez, A. B., Garcia-Perez, A., Cobo, M. and Martin, F. (2013). CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities. PLoS One 8(10): e76979.